Related Experiment Video
Updated: May 14, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Granulocyte colony-stimulating factor receptor signaling: implications for G-CSF responses and leukemic progression
Ivo P Touw1, Karishma Palande, Renée Beekman
1Department of Hematology, Erasmus University Medical Center, Dr Molewaterplein 50 3015 GE, Rotterdam, The Netherlands. i.touw@erasmusmc.nl
Abstract:
Following activation by their cognate ligands, cytokine receptors undergo intracellular routing toward lysosomes, where they are degraded. This review focuses on the signaling function of the G-CSFR in relation to the dynamics of endosomal routing of the G-CSFR. Mechanisms involving receptor lysine ubiquitination and redox-controlled phosphatase activities are discussed. Specific attention is paid to the consequences of G-CSFR mutations, acquired in patients with severe congenital neutropenias who receive G-CSF therapy, particularly in the context of leukemic transformation, a major clinical complication of the disease.
Insights
Granulocyte colony-stimulating factor receptor (G-CSFR) signaling involves lysosomal degradation after ligand activation. This review examines G-CSFR endosomal routing, ubiquitination, and mutations linked to neutropenia and leukemia.
Area of Science:
- Cell Biology
- Molecular Biology
- Hematology
Background:
- Cytokine receptors are internalized and degraded in lysosomes after ligand binding.
- The granulocyte colony-stimulating factor receptor (G-CSFR) plays a critical role in neutrophil development and function.
- Dysregulation of G-CSFR signaling is implicated in hematological disorders.
Purpose of the Study:
- To review the signaling functions of the G-CSFR.
- To explore the dynamics of G-CSFR endosomal routing and degradation.
- To discuss the implications of G-CSFR mutations in severe congenital neutropenia and leukemic transformation.
Main Methods:
- Literature review focusing on G-CSFR intracellular trafficking.
- Analysis of mechanisms including receptor ubiquitination and phosphatase activity.
- Examination of clinical data related to G-CSFR mutations and patient outcomes.
Main Results:
- G-CSFR undergoes regulated endosomal trafficking to lysosomes for degradation following ligand activation.
- Receptor lysine ubiquitination and redox-sensitive phosphatases are key regulators of G-CSFR signaling.
- Specific G-CSFR mutations in neutropenia patients are associated with altered receptor dynamics and increased risk of leukemia.
Conclusions:
- Understanding G-CSFR intracellular routing is crucial for deciphering its signaling.
- Aberrant G-CSFR trafficking and signaling due to mutations contribute to severe congenital neutropenia and leukemogenesis.
- Targeting G-CSFR pathways may offer therapeutic strategies for these conditions.
More Related Videos
07:45A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
Published on: June 27, 2011
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Differentiation of Common Myeloid Progenitor Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Lineage Commitment